SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001232524-23-000051
Filing Date
2023-11-08
Accepted
2023-11-08 16:07:25
Documents
14
Period of Report
2023-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jazz-20231108.htm   iXBRL 8-K 28849
2 EX-99.1 a3q23financialpr.htm EX-99.1 653752
6 GRAPHIC jazzpharma_logoxfullcolor.jpg GRAPHIC 120198
  Complete submission text file 0001232524-23-000051.txt   1028565

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jazz-20231108.xsd EX-101.SCH 1910
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jazz-20231108_lab.xml EX-101.LAB 25957
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jazz-20231108_pre.xml EX-101.PRE 13530
8 EXTRACTED XBRL INSTANCE DOCUMENT jazz-20231108_htm.xml XML 2906
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 231387848
SIC: 2834 Pharmaceutical Preparations